Harvard Intensive Review of Nephrology 2020 (Videos+PDFs)

Harvard Intensive Review of Nephrology 2020

Harvard Medical School and Brigham and Women’s Hospital Board Review.

Product Details

Accreditation

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Harvard Medical School designates this enduring material for a maximum of 44.75 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Original Release: Octiber 15, 2020

Termination Date: January 31, 2023 (Please note that AMA PRA Category 1 Credits ™ will no longer be issued for the activity after this date)

Estimated Time to Complete the Activity: 44.75 hours

CME credit is awarded upon successful completion of a course evaluation and post-test.

ABIM Medical Knowledge MOC Points

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 44.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

On the course evaluation page please indicate “Yes” when asked if you would like to receive ABIM MOC points for your participation in this enduring activity. You will then be required to provide your ABIM ID # and your Date of Birth. Points earned will equal the amount of AMA PRA Category 1 Credits ™ claimed.

HMS will upload the participant data, including the points earned, directly to the ABIM so that it will appear on the ABIM diplomates transcript. These points will not appear on your certificate provided at the end of this enduring activity.

Disclosure Policy

Harvard Medical School (HMS) adheres to all ACCME Accreditation Criteria and Policies. It is HMS’s policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

Disclosure information for all individuals in control of the content of the activity is located on the disclosure statement in the PDF and printed syllabus.

Learning Objectives

After viewing this program, participants will be better able to:

• Summarize current/recommended nephrology guidelines in clinical practice
• Explain the differential diagnosis of complex clinical presentations of patients with renal disorders
• Identify/integrate current therapeutic options for specific renal disorders
• Review and interpret up-to-date literature relevant to clinical practice
• Describe pathophysiological mechanisms as they apply to management of renal disease
• Synthesize teachings to better performance on the ABIM Nephrology certification/recertification examinations

ACGME Competencies

This course is designed to meet one or more of the following Accreditation Council for Graduate Medical Education Competencies:

• Patient Care and Procedural Skills
• Medical Knowledge
• Practice-Based Learning and Improvement

Target Audience

The target audience for the Intensive Review of Nephrology Course is clinical and academic nephrologists, internists, pediatricians, and primary care physicians/trainees preparing for ABIM nephrology certification/recertification examinations and/or seeking a comprehensive update in renal medicine and its subspecialties.

Explore Key Topics in Nephrology

Through lectures, case discussions and board preparation sessions, Intensive Review of Nephrology provides a highly focused look at all major fields of nephrology. Harvard Medical School clinical faculty help you stay current and prepare for exams as they discuss:

• The latest options for diagnosis: what to choose, when, and why
• Current evidence-based treatment and care management strategies to optimize patient outcomes
• Improved approaches to common and complex clinical challenges
• Navigating clinical controversies
• Avoiding medical mistakes
• And more…

Expand Your Skills

Available online or via USB, Intensive Review of Nephrology provides a maximum of 44.75 AMA PRA Category 1 Credits ™ and 44.75 ABIM MOC points and access to unbiased, evidence-based content and case-based reviews so you can prep for exams while learning to incorporate the latest guidelines into your daily practice.

Accreditation

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Harvard Medical School designates this enduring material for a maximum of 44.75 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Original Release: Octiber 15, 2020

Termination Date: January 31, 2023 (Please note that AMA PRA Category 1 Credits ™ will no longer be issued for the activity after this date)

Estimated Time to Complete the Activity: 44.75 hours

CME credit is awarded upon successful completion of a course evaluation and post-test.

ABIM Medical Knowledge MOC Points

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 44.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

On the course evaluation page please indicate “Yes” when asked if you would like to receive ABIM MOC points for your participation in this enduring activity. You will then be required to provide your ABIM ID # and your Date of Birth. Points earned will equal the amount of AMA PRA Category 1 Credits ™ claimed.

HMS will upload the participant data, including the points earned, directly to the ABIM so that it will appear on the ABIM diplomates transcript. These points will not appear on your certificate provided at the end of this enduring activity.

Disclosure Policy

Harvard Medical School (HMS) adheres to all ACCME Accreditation Criteria and Policies. It is HMS’s policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

Disclosure information for all individuals in control of the content of the activity is located on the disclosure statement in the PDF and printed syllabus.

Learning Objectives

After viewing this program, participants will be better able to:

• Summarize current/recommended nephrology guidelines in clinical practice
• Explain the differential diagnosis of complex clinical presentations of patients with renal disorders
• Identify/integrate current therapeutic options for specific renal disorders
• Review and interpret up-to-date literature relevant to clinical practice
• Describe pathophysiological mechanisms as they apply to management of renal disease
• Synthesize teachings to better performance on the ABIM Nephrology certification/recertification examinations

ACGME Competencies

This course is designed to meet one or more of the following Accreditation Council for Graduate Medical Education Competencies:

• Patient Care and Procedural Skills
• Medical Knowledge
• Practice-Based Learning and Improvement

Target Audience

The target audience for the Intensive Review of Nephrology Course is clinical and academic nephrologists, internists, pediatricians, and primary care physicians/trainees preparing for ABIM nephrology certification/recertification examinations and/or seeking a comprehensive update in renal medicine and its subspecialties.

Topics/Speaker:

Glomerulonephritis

• Renal Physiology for the Boards – Melanie P. Hoenig, MD

• Basic Concepts of Immunology in Autoimmune Kidney Disease – Ramon Bonegio, MD

• Renal Pathology in 2020: Part 1 – Helmut G. Rennke, MD

• Renal Pathology in 2020: Part 2 – Astrid Weins, MD, PhD

• Current Approaches to Urine Sediment Analysis – Martina M. McGrath, MD

• IgA Nephropathy – Gerald B. Appel, MD

• Membranous Nephropathy – Laurence H. Beck, Jr., MD, PhD

• ANCA Vasculitis – John L. Niles, MD

• Update on Lupus Nephritis – Gerald B. Appel, MD

• Metabolic Management of Kidney Stones – Gary Curhan, MD, ScD

• Anemia Management: Update and Best Practices – Ajay K. Singh, MBBS, FRCP (UK), MBA

• Glomerulonephritis: Questions & Answers Session – Gerald B. Appel, MD

• Must-Know Clinical Images in Nephrology – Ajay K. Singh, MBBS, FRCP (UK), MBA

• Must-Know Board Zebra – Emily Robinson, MD, MPH

• Nephrology Board Review Practice 1 – Finnian McCausland, MB BCh, MMSc, FRCPI

• Nephrology Board Review Practice 2 – Mallika Mendu, MD

Electrolytes and Acid Base

• Workshop: Hyponatremia and Hypernatremia – David B. Mount, MD

• Hypokalemia and Hyperkalemia – David B. Mount, MD

• Acid-Base Part I – Acidosis – Alan S.L. Yu, MB, BChir

• Acid-Base Part II – Alkalosis – Alan S.L. Yu, MB, BChir

• COVID-19 and Kidney Disease – Daniel Batlle, MD

• Genetics and Kidney Disease – Friedhelm Hildebrandt, MD

• Update on Polycystic Kidney Disease – Cristian Riella, MD

• Pediatric Nephrology – Michael J.G. Somers, MD

• Pregnancy and Renal Disease – Ravi I. Thadhani, MD, MPH

• Electrolyte and Acid Base Disorders – Questions & Answers Session – Part 1 – Alan S.L. Yu, MB, BChir

• Electrolyte and Acid Base Disorders – Questions & Answers Session – Part 2 – Alan S.L. Yu, MB, BChir

• Chronic Kidney Disease in the Community: Meeting Them Where They Are – Li-Li Hsiao, MD, PhD, FACP

Transplantation

• Why Do We Reject a Transplant? – Jamil R. Azzi, MD

• Transplant Immunosuppression for the Boards – Steven Gabardi, PharmD, BCPS, FAST, FCCP

• Immunological Assessment Pre and Post Transplant – Melissa Y. Yeung, MD and Indira Guleria, PhD

• Early Post-Transplant Management – Anil K. Chandraker, MD

• Poisonings and Intoxications: What a Nephrologist Needs to Know – Timothy B. Erickson, MD

• Late Loss of the Kidney Transplant – Andrew M. Siedlecki, MD

• Infections in Transplant Recipients – Sarah P. Hammond, MD

• COVID-19 and Transplant Patients – Enver Akalin, MD, FAST, FASN

• Renal Transplant Recipient Medical Evaluation – Jamil R. Azzi, MD

• Pre-Transplant Surgical Evaluation of Recipients – Sayeed Malek, MD, FACS

• Donor Evaluation – Kassem Safa, MD

• Late Post-Transplant Medical Complications – Leonardo V. Riella, MD, PhD

• Thrombotic Microangiopathies – Jean M. Francis, MD

• Geriatric Nephrology – Ernest I. Mandel, MD

• Transplant Cases: Board Review Practice – Melissa Y. Yeung, MD, and Edgar L. Milford, MD

• Transplant Board Review – Leonardo V. Riella, MD, PhD

CKD and General Nephrology

• Update on Renovascular Disease – Joseph M. Garasic, MD

• Management of Hypertension after SPRINT – Richard J. Glassock, MD

• Secondary Hypertension: Primary Aldosteronism and Pheochromocytoma – Anand Vaidya, MD, MMSc

• Cardiorenal Syndrome – Finnian R. McCausland, MB BCh, MMSc, FRCPI

• Liver and the Kidney – Andrew S. Allegretti, MD, MSc

Acute Kidney Injury

• Pathophysiology of Acute Kidney Injury – Joseph V. Bonventre, MD, PhD

• Acute Kidney Injury Syndromes – Alice Sheridan, MD

• ICU Nephrology and Continuous Renal Replacement Therapies – David J.R. Steele, MB BCh

• COVID-19 in the ICU – Jeremy B. Richards, MD

• Cancer and Acute Kidney Injury – Albert Q. Lam, MD

• Paraprotein Induced Kidney Injury – Albert Q. Lam, MD

• FSGS: A Lesion, Not a Disease – Richard J. Glassock, MD

• Interstitial Nephritis: Overview for the Boards – Julie M. Paik, MD, ScD, MPH

• APOL1 and Kidney Disease – Martin R. Pollak, MD

Dialysis

• Dialysis Dosing – J. Kevin Tucker, MD

• Mineral and Bone Disease – David Bushinsky, MD

• Dialysis: A Case-Based Clinical Review and Update – J. Kevin Tucker, MD

• Pearls in Mineral and Bone Disease – David Bushinsky, MD

• Chronic Kidney Disease Epidemiology: A 2019 Update – Gearoid M. McMahon, MB BCh

• Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC

• Peritoneal Dialysis Complications – Joanne M. Bargman, MD, FRCPC

• COVID-19 and Patients on Dialysis – Giuliano Brunori, MD

• Renal Ultrasound for the Clinical Nephrologist – Adina S. Voiculescu, MD

• Dialysis Vascular Access: Assessment and Complications – Dirk M. Hentschel, MD